Literature DB >> 13180246

Beta-Naphthyl-di-chloroethylamine in the treatment of malignant diseases, particularly Hodgkin's disease.

A VIDEBAEK, S KAAE.   

Abstract

Entities:  

Keywords:  HODGKIN'S DISEASE/therapy; NAPHTHALENE/derivatives; NITROGEN MUSTARDS/therapeutic use

Mesh:

Substances:

Year:  1954        PMID: 13180246     DOI: 10.1111/j.0954-6820.1954.tb11446.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


× No keyword cloud information.
  3 in total

1.  The chemotherapy of malignant disease.

Authors:  R B SCOTT
Journal:  Br Med J       Date:  1958-01-04

2.  Tumor necrosis after the intra-tumor injection of chemical agents and colloidal radioisotopes.

Authors:  S W MAYER; M E MORTON
Journal:  Experientia       Date:  1956-08-15

3.  Tumour-inhibiting action of 1,6-di-(2-bromoethyl-amino)-1,6-dideoxy-D-mannitol dihydrobromide [(DBM (R13)].

Authors:  J BALO; G KENDREY; J JUHASZ; I BESZNYAK
Journal:  Br J Cancer       Date:  1959-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.